Process Validation for Biotechnological Products MasterClass - EU edition
07-10 October, 2024
Today, process validation comprises three main steps:
Stage 1 – Process Design (FDA) or Process Evaluation (EMA)
Stage 2 – Process Qualification (FDA) or Process Verification (EMA)
Continued Process Verification (FDA) or On-going Process Verification (EMA)
07-10 October, 2024, Virtual
Time Zone: UTC/GMT+1 /CET
Overview
Manufacturing processes should be validated prior to initiate commercial manufacturing. Regulatory bodies expect that the manufacturer understand the process so that quality, safety and efficacy of the product are designed or built into the product through the appropriate control of each manufacturing process steps. Today, process validation comprises three main steps: (1) Stage 1 – Process Design (FDA) or Process Evaluation (EMA); (2) Stage 2 – Process Qualification (FDA) or Process Verification (EMA); and (3) Continued Process Verification (FDA) or On-going Process Verification (EMA). The training aims to provide deeper understanding on how process validation for biotechnological processes, which is the collection and evaluation of data from the process design stage through commercial production, would be appropriately designed and executed to establish scientific evidence that a manufacturing process is capable of consistently delivering quality product.
#masterclass #glceurope #pharmaonlinetraining #globalleadingconferences #EUprocessvalidation #biotechnologicalproducts
As of November 2006, I’ve been appointed Vice-President, Head of Biotech Process Sciences at Merck-Serono, based in Vevey, Switzerland, in charge of developing and validating the manufacturing processes for biotechnological products. In that context, whereas Serono was mainly using perfusion processes for recombinant hormones and cytokines, we moved the company to large-scale manufacture of monoclonal antibodies using proprietary chemicallydefined cell culture media and feeds. After our participation to the FDA’s pilot program on Quality by Design, the concepts described in ICH Q8(R2) and ICH Q11 were implemented in our approach to gain process understanding. It was concluded by issuing a modernized approach for process validation at Merck (Darmstadt, Germany). More recently, we have introduced advanced processes such as intensified fed-batch and continuous downstream processing.
RECOMMENDATION
Who should attend?
• Process development scientists and managers
• CMC development program managers
• Pharmaceutical development scientists and managers
• Manufacturing managers
• QC and stability control managers
• Heads of Quality Assurance
• Drug Regulatory Affairs managers
Testimonial
Our success stories
"High attention to detail in course content and very well delivered"
Simon Halsey
Product Development Manager
Essentra Packaging
United Kingdom
Our success stories
"Very good training led by two knowledgeable and open experts. Excellent insight given on many complex topics. Interactive and highly useful"
Aurelie Vivicorsi
USP PD Team Manager
Celonic AG
Switzerland
Our success stories
"Great course, impressed with the knowledge of the trainers and ability to answer wide variety of questions!"
Emilia Szwej
Manager, Senior Investigator
MT Sword Laboratories (BMS)
Germany
About GLC
Global Leadership Conferences began as an ambitious dream by three founders ten years ago. Today it’s an international series of interactive events, exploring the hottest topics in critical fields. Each year, thousands of professionals join us to challenge the status quo and learn innovative ways to create new solutions in Finance, Pharmaceutical, HR, Health & Safety, and Energy.
know more >13+
Years of experience
500+
Events organized
3,970
Speakers
23,714
Attendees
Other events you may like
Drug Product registration process in the US MasterClass
16-19 September, 2024
What the FDA is and how the entity is organized
learn more >>Risk Based Monitoring MasterClass - EU edition
17-18 September, 2024
Learn how to define, evaluate, and respond to risks, and also how to define critical data.
learn more >>Risk Based Monitoring MasterClass - US edition
17-18 September, 2024
Learn how to define, evaluate, and respond to risks, and also how to define critical data.
learn more >>